Tag: multiple sclerosis

TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis

TG Therapeutics (NASDAQ:TGTX) has announced presentation of long-term follow-up data of its Phase 2 open label extension trial of ubiltuximab...

An Investor’s Guide to Multiple Sclerosis

March was dubbed Multiple Scleorsis Awareness Month in 2015 by New Jersey Governor Chris Christie. Here's what investors should know.

Helius Medical Begins Listing on the NASDAQ

A company getting approval to list to the NASDAQ means a more international reach for Canadian companies listing on the...

CBD​ ​is​ ​Improving​ ​Health​ ​and​ ​Driving​ ​the​ ​Cannabis​ ​Industry

CBD​ ​is​ ​improving​ ​health​ ​and​ driving​ ​the​ ​cannabis​ ​industry. Know more about its health benefits and opportunities for CBD-based companies.

Biogen Announces Voluntary Drug Withdrawal and Pfizer Drug Acquisition Weeks Apart, Share Price Remains Steady

March has been a busy month for Biogen with its voluntary withdrawal of Zinbryta and its acquisition of Pfizer's PF-04958242.

Biocure appoints Lichtenwald CFO, director

Biocure Technology Inc. (formerly Gravis Energy Corp.) (CSE: CURE) (the"Company" or "Biocure") is pleased to announce that effective of today's...

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Progress

Atara Biotherapeutics (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases,...